Related Experiment Video
Updated: Aug 16, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Brief report: practicability and safety of amphotericin B deoxycholate as continuous infusion in neutropenic patients
Axel Schulenburg1, Wolfgang Sperr, Werner Rabitsch
1Department of Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Vienna, Austria. axel.schulenburg@meduniwein.ac.at
Abstract:
Fungal infections are a major cause of morbidity and mortality in patients with hematological malignancies. Candida and Aspergillus species are the most important opportunistic fungal pathogens in this patient population. Amphotericin B is the treatment of choice, but its administration is often hampered by severe side-effects, which may be reduced by continuous infusion of this drug. We describe 17 consecutive patients with hematological malignancies, suffering from fever of unknown origin with possible fungal infections, treated with amphotericin B as continuous infusion compared with a control group of 10 patients treated with conventional rapid infusion of amphotericin B over 2 - 6 h. No acute side-effects or severe nephrotoxicity were observed during continuous infusion of amphotericin B. Target doses were reached faster in patients with continuous infusion of amphotericin B than in patients with rapid infusion. We conclude that continuous infusion of amphotericin B is safe in neutropenic patients with hematological malignancies.
Insights
Continuous infusion of Amphotericin B offers a safer and faster way to treat fungal infections in patients with hematological malignancies, reducing severe side effects and nephrotoxicity.
Area of Science:
- Mycology
- Hematology
- Pharmacology
Background:
- Fungal infections pose significant risks for patients with hematological malignancies.
- Candida and Aspergillus species are common opportunistic pathogens in this vulnerable group.
- Amphotericin B is a primary treatment but often causes severe side effects.
Purpose of the Study:
- To evaluate the safety and efficacy of continuous infusion Amphotericin B.
- To compare continuous infusion with rapid infusion of Amphotericin B in neutropenic patients.
Main Methods:
- A comparative study involving 17 patients receiving continuous infusion Amphotericin B and 10 patients receiving rapid infusion.
- Patients had hematological malignancies and fever of unknown origin, suggesting possible fungal infection.
Main Results:
- Continuous infusion of Amphotericin B showed no acute side effects or severe nephrotoxicity.
- Target therapeutic doses of Amphotericin B were achieved more rapidly with continuous infusion.
Conclusions:
- Continuous infusion Amphotericin B is a safe and effective administration method for neutropenic patients with hematological malignancies.
- This method improves treatment delivery compared to conventional rapid infusion.
Related Concept Videos
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
Antifungal Agents
